It’s been a busy year in the cell and gene therapy community and the bloggers at Signals have enjoyed putting the spotlight on news (HeLa settlement and UK rejoins Horizon Europe), scientific advances (improving treatment for hematological malignancies and a new cell therapy for Parkinson’s Disease), career advice (the PhD afterlife and mentorships), improving your “scicomm” skills (helpful tips and using ChatGPT) and people who have inspired us (cancer patient and speaker Suleika Jaouad and parent turned gene therapy entrepreneur Terry Pirovolakis). After a one-year hiatus, we were happy to bring back the blog carnival and welcome new and returning writers. This year’s topic was an exploration of how to support a deluge of new CGT approvals hitting the marketplace.
With about 60 posts in 2023, there is lots of great content to choose from and many bloggers to thank – too many to mention but I appreciate all of them!
Stick around because next week I’ll share the top performing blogs from 2023. Maybe your favourite blogger, or post, will be on the list. If you have one that stands out to you, please comment below.
In recognition of CRISPR/Cas9 being in the news again, here’s a fun video to enjoy. You have to admire the team at A Capella Science for their creativity and talent!
Stacey Johnson
Latest posts by Stacey Johnson (see all)
- Right Turn: #pinksocks, diabetes news and other ramblings - June 24, 2025
- Right Turn: Some takeaways from Advanced Therapies Week 2025 - January 31, 2025
- Right Turn: The top 10 most-read blog posts in 2024 - January 2, 2025
Comments